A platform for the biomedical application of large language models
- PMID: 39843580
- PMCID: PMC12216031
- DOI: 10.1038/s41587-024-02534-3
A platform for the biomedical application of large language models
Conflict of interest statement
Competing interests: J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees or honoraria from Travere Therapeutics, Stadapharm, Pfizer, Grunenthal, Owkin, Moderna and Astex Pharmaceuticals.
Figures


References
-
- Perez-Lopez R, Ghaffari Laleh N, Mahmood F & Kather JN Nat. Rev. Cancer 24, 427–441 (2024). - PubMed
-
- Simon E, Swanson K & Zou J Nat. Methods 21, 1422–1429 (2024). - PubMed
-
- Liesenfeld A & Dingemanse M Rethinking open source generative AI: open-washing and the EU AI Act. In The 2024 ACM Conference on Fairness, Accountability, and Transparency, 10.1145/3630106.3659005 (ACM, 2024). - DOI
-
- UNESCO. UNESCO Recommendation on Open Science. UNESCO; 10.54677/mnmh8546 (2021). - DOI
Publication types
Grants and funding
- R01DK138504/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- 965193/EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
- U54AG075931/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- R01 DK138504/DK/NIDDK NIH HHS/United States
- 101057619/EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
LinkOut - more resources
Full Text Sources